| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |